J.P. Morgan Appointed by Teva Pharmaceutical Industries Ltd. as Successor Depositary Bank for Its ADR Program

  J.P. Morgan Appointed by Teva Pharmaceutical Industries Ltd. as Successor
  Depositary Bank for Its ADR Program

Business Wire

LONDON -- November 07, 2012

J.P.Morgan today announced it has been appointed by Teva Pharmaceutical
Industries Ltd. (Teva) to act as successor depositary bank for the company’s
American Depositary Receipt (ADR) program listed on the New York Stock
Exchange (NYSE). J.P.Morgan will manage the ADR program for Teva, a global
pharmaceutical company based in Israel. The NYSE-listed ADRs trade under the
symbol TEVA and the program ranks among the top three ADR programs in the EMEA
region, by market value.

Alex Hickson, Head of EMEA Regional Depositary Receipts at J.P. Morgan, said:
“We are delighted that Teva has appointed J.P.Morgan to manage their ADR
program. We are confident that our customized ADR services will help Teva meet
their goals to increase visibility within the global investor community and
strengthen their global market presence. Teva joins a line-up of leading
global companies, including many from the pharmaceutical sector, for which
J.P.Morgan acts as depositary bank.”

J.P.Morgan pioneered the depositary receipts market over 85 years ago,
introducing the first ADR in 1927.J.P.Morgan provides a full range of ADR,
GDR and HDR services to issuers seeking to have their equity traded beyond
their home markets. For market information on depositary receipts and
international equities, please go to www.adr.com. More information on J.P.
Morgan’s depositary receipt services is also available on
www.jpmorgan.com/visit/adr.

About J.P. Morgan’s Corporate & Investment Bank

J.P.Morgan’s Corporate & Investment Bank is a global leader across banking,
markets and investor services. The world’s most important corporations,
governments and institutions entrust us with their business in more than 100
countries. With $18.2 trillion of assets under custody and $393 billion in
deposits, the Corporate & Investment Bank provides strategic advice, raises
capital, manages risk and extends liquidity in markets around the world.
Further information about J.P. Morgan is available at www.jpmorgan.com.

Contact:

Media:
J.P.Morgan
Craig MacDonald, +44 20 7134 5341
craig.x.macdonald@jpmchase.com